Cancer stem cells in solid tumours: accumulating evidence and unresolved questions (original) (raw)

• Heppner, G. H. & Miller, B. E. Tumor heterogeneity: biological implications and therapeutic consequences. Cancer Metastasis Rev. 2, 5–23 (1983).
  Article CAS PubMed Google Scholar
• Southam, C. M. & Brunschwig, A. Quantitative studies of autotransplantation of human cancer. Cancer 14, 971–978 (1961).
  Article Google Scholar
• Furth, J. & Kahn, M. C. The transmission of leukemia in mice with a single cell. Am J. Cancer 31, 276–282 (1937).
  Google Scholar
• Hewitt, H. B. Studies of the dissemination and quantitative transplantation of a lymphocytic leukaemia of CBA mice. Br. J. Cancer 12, 378–401 (1958).
  Article CAS PubMed PubMed Central Google Scholar
• Hamburger, A. W. & Salmon, S. E. Primary bioassay of human tumor stem cells. Science 197, 461–463 (1977).
  Article CAS PubMed Google Scholar
• Bonnet, D. & Dick, J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med. 3, 730–737 (1997).
  Article CAS PubMed Google Scholar
• Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105–111 (2001).
  Article CAS PubMed Google Scholar
• Nowell, P. C. The clonal evolution of tumor cell populations. Science 194, 23–28 (1976). A seminal paper describing the clonal evolution of tumour cell populations involving stepwise selection of cells through the acquisition of genetic changes.
  Article CAS PubMed Google Scholar
• Campbell, L. L. & Polyak, K. Breast tumor heterogeneity: cancer stem cells or clonal evolution? Cell Cycle 6, 2332–2338 (2007).
  Article CAS PubMed Google Scholar
• Lapidot, T. et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645–648 (1994).
  Article CAS PubMed Google Scholar
• Barabe, F., Kennedy, J. A., Hope, K. J. & Dick, J. E. Modeling the initiation and progression of human acute leukemia in mice. Science 316, 600–604 (2007). This study reveals that leukaemia stem cells have the potential to evolve with time from a primitive cell type to one containing rearranged immunoglobulin H genes. One implication of this work is that CSCs themselves may be subject to clonal evolution.
  Article CAS PubMed Google Scholar
• Clark, E. A., Golub, T. R., Lander, E. S. & Hynes, R. O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406, 532–535 (2000).
  Article CAS PubMed Google Scholar
• Huntly, B. J. et al. MOZ–TIF2, but not BCR–ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 6, 587–596 (2004).
  Article CAS PubMed Google Scholar
• Krivtsov, A. V. et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9. Nature 442, 818–822 (2006).
  Article CAS PubMed Google Scholar
• Somervaille, T. C. & Cleary, M. L. Identification and characterization of leukemia stem cells in murine MLL–AF9 acute myeloid leukemia. Cancer Cell 10, 257–268 (2006).
  Article CAS PubMed Google Scholar
• Cozzio, A. et al. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev. 17, 3029–3035 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Chen, W. et al. Malignant transformation initiated by Mll_–_AF9: gene dosage and critical target cells. Cancer Cell 13, 432–440 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Jamieson, C. H. et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med. 351, 657–667 (2004).
  Article CAS PubMed Google Scholar
• Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983–3988 (2003). This paper provides the first description of the prospective purification of tumour-initiating cells from a solid malignancy, breast cancer.
  Article CAS PubMed PubMed Central Google Scholar
• Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396–401 (2004). The first demonstration of CSCs in brain tumours through the use of CD133 for prospective isolation.
  Article CAS PubMed Google Scholar
• Bao, S. et al. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res. 66, 7843–7848 (2006).
  Article CAS PubMed Google Scholar
• Beier, D. et al. CD133+ and CD133− glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 67, 4010–4015 (2007).
  Article CAS PubMed Google Scholar
• Taylor, M. D. et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8, 323–335 (2005).
  Article CAS PubMed Google Scholar
• Bao, S. et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756–760 (2006).
  Article CAS PubMed Google Scholar
• Piccirillo, S. G. et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444, 761–765 (2006). These studies reveal that CSCs in gliomas appear to have different properties from the bulk of the population. Reference 24 shows that they are more radioresistant and reference 25 demonstrates that they are responsive to BMP-induced differentiation.
  Article CAS PubMed Google Scholar
• O'Brien, C. A., Pollett, A., Gallinger, S. & Dick, J. E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106–110 (2007).
  Article CAS PubMed Google Scholar
• Ricci-Vitiani, L. et al. Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111–115 (2007).
  Article CAS PubMed Google Scholar
• Hermann, P. C. et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1, 313–323 (2007). These findings support the concept of a distinct metastatic CSC with important implications for designing drugs that specifically target the metastatic CSC.
  Article CAS PubMed Google Scholar
• Uchida, N. et al. Direct isolation of human central nervous system stem cells. Proc. Natl Acad. Sci. USA 97, 14720–14725 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Lee, A. et al. Isolation of neural stem cells from the postnatal cerebellum. Nature Neurosci. 8, 723–729 (2005).
  Article CAS PubMed Google Scholar
• Oshima, Y. et al. Isolation of mouse pancreatic ductal progenitor cells expressing CD133 and c-Met by flow cytometric cell sorting. Gastroenterology 132, 720–732 (2007).
  Article CAS PubMed Google Scholar
• Dalerba, P. et al. Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl Acad. Sci. USA 104, 10158–10163 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Ginestier, C. et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1, 555–567 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Wright, M. H. et al. Brca1 breast tumors contain distinct CD44+/CD24− and CD133− cells with cancer stem cell characteristics. Breast Cancer Res. 10, R10 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Schatton, T. et al. Identification of cells initiating human melanomas. Nature 451, 345–349 (2008). This study reveals that expression of the CSC marker and drug transporter protein ABCB5 in melanoma correlates with clinical progression.
  Article CAS PubMed PubMed Central Google Scholar
• Kern, S. E. & Shibata, D. The fuzzy math of solid tumor stem cells: a perspective. Cancer Res. 67, 8985–8988 (2007).
  Article CAS PubMed Google Scholar
• Bonnefoix, T., Bonnefoix, P., Verdiel, P. & Sotto, J. J. Fitting limiting dilution experiments with generalized linear models results in a test of the single-hit Poisson assumption. J. Immunol. Methods 194, 113–119 (1996).
  Article CAS PubMed Google Scholar
• Zeppernick, F. et al. Stem cell marker CD133 affects clinical outcome in glioma patients. Clin. Cancer Res. 14, 123–129 (2008).
  Article CAS PubMed Google Scholar
• Patrawala, L. et al. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25, 1696–1708 (2006).
  Article CAS PubMed Google Scholar
• Patrawala, L. et al. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2− cancer cells are similarly tumorigenic. Cancer Res. 65, 6207–6219 (2005).
  Article CAS PubMed Google Scholar
• Collins, A. T., Berry, P. A., Hyde, C., Stower, M. J. & Maitland, N. J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65, 10946–10951 (2005).
  Article CAS PubMed Google Scholar
• Eramo, A. et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 15, 504–514 (2008).
  Article CAS PubMed Google Scholar
• Neering, S. J. et al. Leukemia stem cells in a genetically defined murine model of blast-crisis CML. Blood 110, 2578–2585 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Yilmaz, O. H. et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441, 475–482 (2006).
  Article CAS PubMed Google Scholar
• Kelly, P. N., Dakic, A., Adams, J. M., Nutt, S. L. & Strasser, A. Tumor growth need not be driven by rare cancer stem cells. Science 317, 337 (2007). This paper has challenged the CSC hypothesis, following the observation that three mouse models of leukaemia and lymphoma are maintained by a dominant cell population. The authors posit that xenotransplantation may select for tumour cells capable of surviving in a foreign environment.
  Article CAS PubMed Google Scholar
• Cho, R. W. et al. Isolation and molecular characterization of cancer stem cells in MMTV–Wnt-1 murine breast tumors. Stem Cells 26, 364–371 (2008).
  Article CAS PubMed Google Scholar
• Vaillant, F., Asselin-Labat, M. L., Shackleton, M., Lindeman, G. J. and Visvader, J. E. The mammary progenitor marker CD61/b3integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer Res. (in the press).
• Zhang, M. et al. Identification of tumor-initiating cells in a p53 null mouse model of breast cancer. Cancer Res. 68, 4674–4682 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Malanchi, I. et al. Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling. Nature 452, 650–653 (2008). References 46–49 provide definitive evidence for the existence of CSCs in syngeneic mouse models of mammary and skin tumorigenesis. They further suggest that normal stem and progenitor markers have utility in the identification and isolation of CSCs.
  Google Scholar
• Thiery, J. P. Epithelial–mesenchymal transitions in tumour progression. Nature Rev. Cancer 2, 442–454 (2002).
  Article CAS Google Scholar
• Mani, S. A. et al. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc. Natl Acad. Sci. USA 104, 10069–10074 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Kaplan, R. N. et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820–827 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Yang, Z. F. et al. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 13, 153–166 (2008).
  Article CAS PubMed Google Scholar
• Light, R. W., Erozan, Y. S. & Ball, W. C. Jr. Cells in pleural fluid. Their value in differential diagnosis. Arch. Intern. Med. 132, 854–860 (1973).
  Article CAS PubMed Google Scholar
• Liu, R. et al. The prognostic role of a gene signature from tumorigenic breast-cancer cells. N. Engl. J. Med. 356, 217–226 (2007).
  Article CAS PubMed Google Scholar
• Shipitsin, M. et al. Molecular definition of breast tumor heterogeneity. Cancer Cell 11, 259–273 (2007).
  Article CAS PubMed Google Scholar
• Shmelkov, S. V. et al. CD133 expression is not restricted to stem cells, and both CD133 and CD133 metastatic colon cancer cells initiate tumors. J. Clin. Invest. 118, 2111–2120 (2008).
  CAS PubMed PubMed Central Google Scholar
• Carpenter, G. & Cohen, S. Epidermal growth factor. Annu. Rev. Biochem. 48, 193–216 (1979).
  Article CAS PubMed Google Scholar
• Rifkin, D. B. & Moscatelli, D. Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol. 109, 1–6 (1989).
  Article CAS PubMed Google Scholar
• Kuperwasser, C. et al. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc. Natl Acad. Sci. USA 101, 4966–4971 (2004). This study represents an important step in establishing humanized mouse models for solid tumours, demonstrating that a species-specific stromal niche is important for the growth of human epithelial cells.
  Article CAS PubMed PubMed Central Google Scholar
• Gupta, P. B. et al. Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers. Cancer Res. 67, 2062–2071 (2007).
  Article CAS PubMed Google Scholar
• Takenaka, K. et al. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nature Immunol. 8, 1313–1323 (2007).
  Article CAS Google Scholar
• Shultz, L. D. et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2Rγ null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 174, 6477–6489 (2005).
  Article CAS PubMed Google Scholar
• Galli, R. et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64, 7011–7021 (2004).
  Article CAS PubMed Google Scholar
• Li, C. et al. Identification of pancreatic cancer stem cells. Cancer Res. 67, 1030–1037 (2007).
  Article CAS PubMed Google Scholar
• Bissell, M. J. & Labarge, M. A. Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? Cancer Cell 7, 17–23 (2005).
  CAS PubMed PubMed Central Google Scholar
• Mehta, R. R., Graves, J. M., Hart, G. D., Shilkaitis, A. & Das Gupta, T. K. Growth and metastasis of human breast carcinomas with Matrigel in athymic mice. Breast Cancer Res. Treat. 25, 65–71 (1993).
  Article CAS PubMed Google Scholar
• Henson, B. et al. An orthotopic floor-of-mouth model for locoregional growth and spread of human squamous cell carcinoma. J. Oral Pathol. Med. 36, 363–370 (2007).
  Article CAS PubMed Google Scholar
• Prokhorova, T. A. et al. Teratoma formation by human embryonic stem cells is site-dependent and enhanced by the presence of Matrigel. Stem Cells Dev. 7 Apr 2008 (doi:10.1089/scd.2007.0266).
• Marshall, G. P. 2nd, Reynolds, B. A. & Laywell, E. D. Using the neurosphere assay to quantify neural stem cells in vivo. Curr. Pharm. Biotechnol. 8, 141–145 (2007).
  Article CAS PubMed Google Scholar
• Reynolds, B. A. & Rietze, R. L. Neural stem cells and neurospheres — re-evaluating the relationship. Nature Meth. 2, 333–336 (2005). The sphere assay, originally developed for neural cells, has formed an important basis for the development of an in vitro assay to study both normal stem and progenitor cells and tumour-initiating cells in a variety of solid tumours including brain (reference 73) and breast (reference 78).
  Article CAS Google Scholar
• Kondo, T. & Raff, M. Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells. Science 289, 1754–1757 (2000).
  Article CAS PubMed Google Scholar
• Hemmati, H. D. et al. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl Acad. Sci. USA 100, 15178–15183 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Clement, V., Sanchez, P., de Tribolet, N., Radovanovic, I. & Ruiz i Altaba, A. HEDGEHOG–GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr. Biol. 17, 165–172 (2007).
  Article CAS PubMed Google Scholar
• Diamandis, P. et al. Chemical genetics reveals a complex functional ground state of neural stem cells. Nature Chem. Biol. 3, 268–273 (2007).
  Article CAS Google Scholar
• Beier, D. et al. Temozolomide preferentially depletes cancer stem cells in glioblastoma. Cancer Res. 68, 5706–5715 (2008).
  Article CAS PubMed Google Scholar
• Yu, F. et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131, 1109–1123 (2007).
  Article CAS PubMed Google Scholar
• Dontu, G. et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17, 1253–1270 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Ishikawa, F. et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nature Biotechnol. 25, 1315–1321 (2007).
  Article CAS Google Scholar
• Ito, K. et al. PML targeting eradicates quiescent leukaemia-initiating cells. Nature 453, 1072–1078 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Shachaf, C. M. et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431, 1112–1117 (2004).
  Article CAS PubMed Google Scholar
• Guzman, M. L. et al. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 105, 4163–4169 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Jin, L., Hope, K. J., Zhai, Q., Smadja-Joffe, F. & Dick, J. E. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nature Med. 12, 1167–1174 (2006).
  Article PubMed CAS Google Scholar
• Krause, D. S., Lazarides, K., von Andrian, U. H. & Van Etten, R. A. Requirement for CD44 in homing and engraftment of BCR–ABL-expressing leukemic stem cells. Nature Med. 12, 1175–1180 (2006).
  Article CAS PubMed Google Scholar
• Lee, J. et al. Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell 13, 69–80 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Walkley, C. R. et al. A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor γ deficiency. Cell 129, 1097–1110 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Calabrese, C. et al. A perivascular niche for brain tumor stem cells. Cancer Cell 11, 69–82 (2007). This study and reference 21 suggest that CSCs in tumours are maintained by an aberrant vascular niche and that glioblastoma CSCs have potent angiogenic activity.
  Article CAS PubMed Google Scholar
• Folkins, C. et al. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors. Cancer Res. 67, 3560–3564 (2007).
  Article CAS PubMed Google Scholar
• Hambardzumyan, D. et al. PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes Dev. 22, 436–448 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Blazek, E. R., Foutch, J. L. & Maki, G. Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133− cells, and the CD133+ sector is enlarged by hypoxia. Int. J. Radiat. Oncol. Biol. Phys. 67, 1–5 (2007).
  Article CAS PubMed Google Scholar
• Phillips, T. M., McBride, W. H. & Pajonk, F. The response of CD24−/low/CD44+ breast cancer-initiating cells to radiation. J. Natl Cancer Inst. 98, 1777–1785 (2006).
  Article PubMed Google Scholar
• Woodward, W. A. et al. WNT/β-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc. Natl Acad. Sci. USA 104, 618–623 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Al-Hajj, M. Cancer stem cells and oncology therapeutics. Curr. Opin. Oncol. 19, 61–64 (2007).
  PubMed Google Scholar
• Li, X. et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J. Natl Cancer Inst. 100, 672–679 (2008). References 77 and 94 provide evidence for a subpopulation of chemotherapy-resistant cancer-initiating cells in breast cancer patients.
  Article CAS PubMed Google Scholar
• Shafee, N. et al. Cancer stem cells contribute to cisplatin resistance in Brca1/_p53_-mediated mouse mammary tumors. Cancer Res. 68, 3243–3250 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Dylla, S. J. et al. Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PLoS ONE 3, e2428 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Todaro, M. et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1, 389–402 (2007).
  Article CAS PubMed Google Scholar
• Johnstone, R. W., Cretney, E. & Smyth, M. J. P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death. Blood 93, 1075–1085 (1999).
  CAS PubMed Google Scholar
• Blair, A., Hogge, D. E., Ailles, L. E., Lansdorp, P. M. & Sutherland, H. J. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood 89, 3104–3112 (1997).
  CAS PubMed Google Scholar
• Jordan, C. T. et al. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia 14, 1777–1784 (2000).
  Article CAS PubMed Google Scholar
• Chang, H. H., Hemberg, M., Barahona, M., Ingber, D. E. & Huang, S. Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature 453, 544–547 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Hope, K. J., Jin, L. & Dick, J. E. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nature Immunol. 5, 738–743 (2004).
  Article CAS Google Scholar
• Kleinsmith, L. J. & Pierce, G. B., Jr. Multipotentiality of single embryonal carcinoma cells. Cancer Res. 24, 1544–1551 (1964).
  CAS PubMed Google Scholar
• Lowe, S. W. & Sherr, C. J. Tumor suppression by _Ink4a_-Arf: progress and puzzles. Curr. Opin. Genet. Dev. 13, 77–83 (2003).
  Article CAS PubMed Google Scholar
• Molofsky, A. V., He, S., Bydon, M., Morrison, S. J. & Pardal, R. Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev. 19, 1432–1437 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Pardal, R., Molofsky, A. V., He, S. & Morrison, S. J. Stem cell self-renewal and cancer cell proliferation are regulated by common networks that balance the activation of proto-oncogenes and tumor suppressors. Cold Spring Harb. Symp. Quant. Biol. 70, 177–185 (2005).
  Article CAS PubMed Google Scholar
• Leung, C. et al. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 428, 337–341 (2004).
  Article CAS PubMed Google Scholar
• Reya, T. & Clevers, H. Wnt signalling in stem cells and cancer. Nature 434, 843–850 (2005).
  Article CAS PubMed Google Scholar
• He, X. C., Zhang, J. & Li, L. Cellular and molecular regulation of hematopoietic and intestinal stem cell behavior. Ann. N. Y. Acad. Sci. 1049, 28–38 (2005).
  Article CAS PubMed Google Scholar
• Haramis, A. P. et al. De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science 303, 1684–1686 (2004).
  Article CAS PubMed Google Scholar
• He, X. C. et al. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt–β-catenin signaling. Nature Genet. 36, 1117–1121 (2004).
  Article CAS PubMed Google Scholar
• Ming Kwan, K., Li, A. G., Wang, X. J., Wurst, W. & Behringer, R. R. Essential roles of BMPR-IA signaling in differentiation and growth of hair follicles and in skin tumorigenesis. Genesis 39, 10–25 (2004).
  Article PubMed CAS Google Scholar
• Ayyanan, A. et al. Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism. Proc. Natl Acad. Sci. USA 103, 3799–3804 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Shackleton, M. et al. Generation of a functional mammary gland from a single stem cell. Nature 439, 84–88 (2006).
  Article CAS PubMed Google Scholar
• Zhao, C. et al. Loss of β-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 12, 528–541 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Mizrak, D., Brittan, M. & Alison, M. R. CD133: molecule of the moment. J. Pathol. 214, 3–9 (2008).
  Article CAS PubMed Google Scholar
• Prince, M. E. et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl Acad. Sci. USA 104, 973–978 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Wu, C. et al. Side population cells isolated from mesenchymal neoplasms have tumor initiating potential. Cancer Res. 67, 8216–8222 (2007).
  Article CAS PubMed Google Scholar
• Clarke, M. F. et al. Cancer stem cells — perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 66, 9339–9344 (2006).
  Article CAS PubMed Google Scholar
• Singh, S. K. et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 63, 5821–5828 (2003).
  CAS PubMed Google Scholar